Takashi K. Satoh

Dermatology

1150 Northwest 14th Street
Miami, FL 33136

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Type I and II Interferon Signalling Characterizes the Transcriptional Landscape of Sweet Syndrome.

Type I and II Interferon Signalling Characterizes the Transcriptional Landscape of Sweet Syndrome.

Journal: Experimental dermatology

Published: March 02, 2026

The IL-36 cytokine family: From barrier immunity to therapeutic target in inflammatory diseases.

The IL-36 cytokine family: From barrier immunity to therapeutic target in inflammatory diseases.

Journal: Allergology international : official journal of the Japanese Society of Allergology

Published: January 20, 2026

Cutting-edge multiomic approaches shed light on the interleukin-36 axis in Sweet syndrome.

Cutting-edge multiomic approaches shed light on the interleukin-36 axis in Sweet syndrome.

Journal: The British journal of dermatology

Published: November 10, 2025

Scarring hidradenitis suppurativa with phrynoderma-like eruption, alopecia, and elevated interleukin 18.

Scarring hidradenitis suppurativa with phrynoderma-like eruption, alopecia, and elevated interleukin 18.

Journal: JAAD case reports

Published: January 21, 2025

Sweet syndrome: an update on clinical aspects, pathophysiology, and treatment.

Sweet syndrome: an update on clinical aspects, pathophysiology, and treatment.

Journal: Italian journal of dermatology and venereology

Published: November 19, 2024

LL37 complexed to double-stranded RNA induces RIG-I-like receptor signalling and Gasdermin E activation facilitating IL-36γ release from keratinocytes.

LL37 complexed to double-stranded RNA induces RIG-I-like receptor signalling and Gasdermin E activation facilitating IL-36γ release from keratinocytes.

Journal: Cell death & disease

Published: November 02, 2024

Recent progress in Stevens-Johnson syndrome/toxic epidermal necrolysis: diagnostic criteria, pathogenesis and treatment.

Recent progress in Stevens-Johnson syndrome/toxic epidermal necrolysis: diagnostic criteria, pathogenesis and treatment.

Journal: The British journal of dermatology

Published: July 02, 2024

Author reply.

Author reply.

Journal: The Journal of dermatology

Published: March 25, 2024

Genetic mutations in pyoderma gangrenosum, hidradenitis suppurativa, and associated autoinflammatory syndromes: Insights into pathogenic mechanisms and shared pathways.

Genetic mutations in pyoderma gangrenosum, hidradenitis suppurativa, and associated autoinflammatory syndromes: Insights into pathogenic mechanisms and shared pathways.

Journal: The Journal of dermatology

Published: September 26, 2023

Spatial proteomics identifies JAKi as treatment for a lethal skin disease.

Spatial proteomics identifies JAKi as treatment for a lethal skin disease.

Journal: Nature

Published: September 13, 2023

Immune checkpoint inhibitor-induced epidermal necrolysis: A narrative review evaluating demographics, clinical features, and culprit medications.

Immune checkpoint inhibitor-induced epidermal necrolysis: A narrative review evaluating demographics, clinical features, and culprit medications.

Journal: The Journal of dermatology

Published: July 24, 2023

Role of the NLRP1 inflammasome in skin cancer and inflammatory skin diseases.

Role of the NLRP1 inflammasome in skin cancer and inflammatory skin diseases.

Journal: The British journal of dermatology

Published: July 05, 2023

Showing 1-12 of 25

Last Updated: 09/26/2026